What are the suitable populations for assisted reproduction in Kyrgyzstan? Analysis of Different Physical Conditions and Choice Paths

Judge first: Which choice path do you belong to?

"Kyrgyzstan's assisted reproduction is suitable for the population" is not a list divided only by age. What really determines whether a person is suitable to go to the local area for assisted reproductive assessment is usually medical needs, previous treatment experience, time arrangement, institutional capacity, and my ability to withstand the cross-border medical treatment process.

The World Health Organization regards infertility as a reproductive system disease that needs standardized diagnosis and treatment, and emphasizes that the treatment should be based on the cause and personal situation, rather than directly guiding everyone to the same technology.

You can first judge the direction through the following decision table:

Whether the personal situation is worthy of further consultation needs to be verified.

Age and long pregnancy preparation time can enter the medical evaluation of ovarian reserve, uterine condition and previous pregnancy history.

If AMH is decreased or basal follicles are less, you can consult the age of individualized regimen, AFC and previous ovulation induction reactions, not just the single value.

After many treatments, the ideal results have not been obtained, which is suitable for systematic re-recording of embryos, intimal condition, laboratory process and treatment plan.

The persistent abnormality of male semen index is suitable for both husband and wife to evaluate semen analysis, andrology history and whether further examination is needed.

Family hereditary disease history or chromosome problems are suitable for genetic consultation, pathogenic information, detection boundary and embryo number expectation.

I only hope to get the result, and promise not to make a hasty decision. The medical result is affected by age, embryo, uterus and individual reaction.

Basic health problems, such as endocrine, infection, cardiovascular and pregnancy tolerance, should be dealt with first if the basic physical diseases are not controlled.

Unable to cope with the cross-border time and material preparation, it is necessary to reassess the destination round-trip arrangement, follow-up connection, language communication and document verification.

This form can only be used for direction judgment, and can't replace the doctor's face-to-face consultation. Whether it is suitable for assisted reproduction in Kyrgyzstan cannot be decided only by online cases, institutional publicity or an inspection report.

Path A: Age increases or ovarian reserve changes.

One kind of common consultants is people who are getting older, the pregnancy preparation time is prolonged, or the indexes such as AMH, FSH and AFC have changed. Their concern is often not simply whether they can do it, but how much time is available, what kind of treatment rhythm should be adopted, and what results may be obtained in one cycle.

This kind of population can take Kyrgyzstan as the evaluation direction, but AMH cannot be directly understood as the success rate. According to the American Society of Reproductive Medicine, AMH and the number of basal follicles are more suitable for estimating the ovarian response to ovulation-promoting drugs and the number of eggs that may be obtained. It is not possible to predict the outcome of natural conception or assisted reproduction independently of age, medical history and previous treatment.

The situations worthy of further consultation mainly include:

Over 35 years old, pregnant for a period of time and still not pregnant, I hope to complete the systematic evaluation as soon as possible;

The menstrual cycle changes, accompanied by the decline of ovarian reserve;

The number of eggs obtained by previous ovulation promotion is small, so it is necessary to redesign the medication and cycle rhythm;

Because of work or family planning, I hope to form a clear timetable for examination, ovulation promotion, embryo culture and follow-up arrangements;

After many visits in China, there is still a lack of complete answers, and I hope to get another set of medical evaluation opinions.

Age does not mean that you can only choose a certain scheme, and the low ovarian reserve does not mean that there is no room for treatment. It is more reasonable to put age, basic hormones, basic follicles, previous eggs, embryo development records and uterine conditions in the same evaluation data.

Path B: Repeated failure, abortion history or complicated etiology.

Some people are not exposed to assisted reproduction for the first time, but have experienced ovulation promotion, embryo culture or transplantation, but have not achieved ideal results. For such people, just changing countries can't solve the problem. What is really valuable is to re-examine every link in the past.

The suggestion of the European Society of Human Reproduction and Embryology on repeated implantation failure suggests that individual evaluation should be combined with age, embryo condition, uterine and endometrial factors and previous treatment process; Additional examinations and treatments with insufficient evidence should also be used with caution.

Before going to Kyrgyzstan for consultation, it is recommended to prepare the following information:

Previous ovulation promotion schemes, dosage and follicular growth records;

Number of eggs taken, number of mature eggs, fertilization mode and embryo culture results;

Embryonic stage, intimal condition, hormone level and medication record of each transplantation;

Uterine cavity examination, ultrasound, fallopian tube condition and abortion related examination;

Male semen report, disease history and previous treatment data.

An organization worthy of continuous communication should not only give a reply of "doing a new cycle", but also explain what limitations the old scheme may have, which inspections are really necessary, and what are the actual differences between the old and new schemes.

For those who fail repeatedly, we should also be alert to the practice of constantly overlapping inspection items. A large number of examinations does not mean that the scheme is more rigorous. The key lies in whether each examination can affect the subsequent medical decision.

Path C: Male factors or genetic risks need to be dealt with simultaneously.

Assisted reproduction is not just about examining women. Sperm quantity, motility, morphology and some andrology diseases may affect fertilization and embryo development. If the man has persistent abnormal semen indexes, diseases of genitourinary system, history of surgery or family genetic problems, both husband and wife should make simultaneous assessment to avoid the missing of key data after the woman completes ovulation promotion.

Male factors suitable for further understanding of assisted reproduction in Kyrgyzstan include:

The results of many semen tests were abnormal;

Have received urogenital surgery or related treatment;

In previous cycles, fertilization rate was low or embryo development was blocked;

Long-term exposure to high temperature, chemicals or life factors affecting fertility;

It is necessary for reproductive department and andrology department to work out a treatment plan together.

Another kind of people who are suitable for consultation in advance is that one of the husband and wife has a definite monogenic disease, abnormal chromosome structure, or a certain hereditary disease appears repeatedly in the family.

Such families should first complete genetic counseling to confirm whether the pathogenic information is clear, whether the laboratory can establish a testing scheme, and what boundaries may exist in testing. Preimplantation genetic testing is not a screening item needed by the general population, and its applicability should be judged according to the disease type, family data and personal situation.

When selecting relevant institutions in Kyrgyzstan, we should also ask about the cooperation mode of genetic laboratories, how to manage samples, who will interpret reports, how to check abnormal results, and whether the team can provide clear cross-language communication.

Who should not regard cross-border assisted reproduction as an immediate plan?

It is not suitable to leave the country immediately because of fertility difficulties. The following types of situations are more suitable for completing the examination or treatment at the place of residence first.

The underlying disease is not yet stable. For example, serious cardiovascular diseases, uncontrolled thyroid or blood sugar problems, active infections, and doctors' judgment that pregnancy may obviously aggravate the condition, should be jointly evaluated by relevant specialties and reproductive departments.

The inspection data is too scattered. It is easy to make a judgment deviation when deciding the scheme only by an AMH or a semen report. Individual indicators may be affected by testing time, drugs, laboratory methods and physical condition, and a complete medical history is usually more valuable than a single report.

Just look at the success rate in agency publicity. Different age, etiology, embryonic stage and statistical caliber cannot be directly compared together. When consulting, you should ask what kind of patients the data corresponds to, what is the statistical cycle, and whether it is calculated according to the transplantation cycle or the cumulative cycle.

Unable to cooperate with cross-border follow-up visits. Assisted reproduction may involve cycle adjustment, reexamination, communication of embryo results and connection of subsequent medication. If it is difficult to adjust the working hours, or there is no doctor to continue management after returning home, we should first confirm how the medical teams in the two places cooperate.

Understanding the change of country as the result of change. The country is only the place for medical treatment, and the real factors affecting the program are still age, etiology, doctor's judgment, embryo laboratory management and personal physical reaction.

Complete the "four-column checklist" before going to Kyrgyzstan for medical treatment.

To judge whether you are suitable for assisted reproduction in Kyrgyzstan, you can divide the information into four columns.

Medical column: age, menstrual cycle, AMH, basic hormones, AFC, uterine and ovarian ultrasound, previous pregnancy history, surgical history, chronic diseases and medication.

Treatment column: previous ovulation promotion times, egg acquisition and fertilization, embryo culture records, transplantation records, failed nodes and doctors' opinions.

Institutional column: hospital qualification, doctor's practice information, embryo laboratory process, scheme interpretation method, privacy management, emergency treatment and follow-up connection after returning to China.

Cross-border column: entry and stay requirements, translation services, authenticity of materials, contractual responsibility boundary, payment node, and how to deal with the cancellation or change of the cycle.

Cross-border medical policies, the scope of institutional consultation and material requirements may be adjusted. Check with hospitals, local authorities or professionals with corresponding qualifications before departure, and don't rely solely on relayed information or past cases.

People without obvious diseases can also go for consultation, but it does not mean that they need to enter treatment immediately. If the pregnancy time is still short, the age is young and there is no clear abnormality, the doctor may suggest that the basic fertility assessment be completed first, or continue to try for a period of time. WHO guidelines for diagnosis and treatment of infertility emphasize that the treatment path should be selected step by step according to the cause, age, course of disease and personal situation.

Assisted reproduction in Kyrgyzstan is suitable for people, not a simple collection of a certain age or a certain disease. The more reasonable criteria are: whether there is a clear medical demand, whether a more systematic individualized plan is needed, whether a medical institution with transparent process and matching ability can be found, and whether I can bear the time, communication and follow-up requirements brought by cross-border medical treatment.

Kyrgyzstan can be used as one of the evaluation directions for people with advanced age, declining ovarian reserve, repeated treatment failing to meet expectations, male factors or genetic risk; For people with unstable basic diseases, incomplete data or only expecting results and promises, decision-making should be suspended first. It is usually safer to diagnose the problem first and then choose the country and institution than to determine the destination first and then find the reason.